OptiNose Inc (OPTN): Total Asset Value of Company

Graphic logo of Optinose (OPTN)

The prospects for OptiNose, Inc. (OPTN) rely on market demand for sinusitis sprays and a moderate level of operating profit. Management is skillfully developing niche sales segments while maintaining reporting transparency for US insurers. The price action vector available for analysis on GURU.Markets based on total assets, which is 99.27, complements the picture of automated production of high-precision components for drug delivery systems.

OptiNose, Inc. (OPTN) Company Total Assets: for the period 07/04/2022 - 05/31/2025

Comprehensive metric breakdowns and analytics for Optinose (OPTN)

- price and consensus price forecast:
Share Price optinose.com|OPTN - Price Target Chart
- market capitalization data:
Market Valuation OptiNose Corp|OPTN - Enterprise Value
- book capitalization data:
Accounting Value of a Share OptiNose|OPTN - Book Capitalization|Market Capitalization to Book Value Ratio optinose.com|OPTN - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio OptiNose, Inc.|OPTN - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio OptiNose Corp|OPTN - Company Aggregate Debts|Debts to Book Capitalization OptiNose Corp|OPTN - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings OptiNose
Fundamental valuation:OPTN, optinose.com
Finished products of OptiNose, Inc.

Total assets determine a company's resource potential, combining capital and liabilities to assess financial stability via a reverse ROA calculation. By analyzing the total asset trends of the enterprise, an investor can discern the balance between bankruptcy protection and servicing costs, which for OptiNose, Inc. (OPTN) confirms the capitalization of its patent portfolio for nasal delivery devices that ensure stable demand for the treatment of sinusitis.

Competitors of OptiNose, Inc. (OPTN)

HLN (haleon.com) - Total Business Assets|Aggregate Company Assets Kenvue KVUE|Total Asset Value of Company Verona Pharma PLC|Jyong Biotech Corp (MENS) - Company Total Assets|Aggregate Asset Value Ligand Corp (LGND)|Company Total Assets AMRX (Amneal Pharmaceuticals)|perrigo.com - Company Total Assets|Aggregate Company Assets Alvotech SA (ALVO)|LQDA: Aggregate Asset Value|GLPG (Galapagos Genomics) - Aggregate Company Assets|ANI Pharmaceuticals Corp (ANIP) - Cumulative Company Assets|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com (AMPH)|Pacira BioSciences, Inc. (PCRX) - Cumulative Company Assets|Aggregate Asset Value SPRY (ARS Pharmaceuticals Inc)|TBPH: Aggregate Company Assets|AQST - Company Assets|Cumulative Company Assets scPharma SCPH|TECX - Aggregate Business Assets|Company Total Assets Tonix Pharmaceuticals Holding Corp. TNXP|China SXT Pharmaceuticals, Inc. (SXTC) - Aggregate Asset Value|Company Total Assets EPRX (Eupraxia Pharmaceuticals, Inc.)|Company Assets BHST|eXoZymes Inc (EXOZ) - Aggregate Company Assets|Aggregate Asset Value ORMP (oramed.com)|ENTX: Aggregate Company Assets|MindWalk Holdings, Inc. - Company Assets|Aggregate Company Assets ABVC BioPharma Inc|Cumberland Corp (CPIX) - Total Asset Value of Company|QNTM - Cumulative Company Assets|fibrogen.com (FGEN) - Aggregate Business Assets|TELO: Company Total Assets|Company Total Asset Base RANI|Aggregate Company Assets Synergy CHC Corp SNYR|Total Business Assets RLYB (rallybio.com)|LEXX: Aggregate Company Assets|pulmatrix.com - Company Assets|Aggregate Company Assets PTHL (Pheton)|APM - Company Total Asset Base|Company Total Assets LYRA|Company Assets Impact BioMedical, Inc.|TNFA - Cumulative Company Assets|Aggregate Asset Value cbdMD Corp|PRFX (PainReform) - Company Total Assets|Company Total Asset Base CYTO (altamiratherapeutics.com)|LIPO - Aggregate Company Assets|Total Business Assets Pieris Pharma PIRS|PROC: Company Total Assets|petrospharma.com (PTPI) - Cumulative Company Assets|Qilian International Holding - Cumulative Company Assets|SLRN (Acelyrin Inc.) - Company Total Asset Base|Aggregate Company Assets TFFP (TFF Pharma)